vs

Side-by-side financial comparison of Atlantic Union Bankshares Corp (AUB) and Harmony Biosciences Holdings, Inc. (HRMY). Click either name above to swap in a different company.

Atlantic Union Bankshares Corp is the larger business by last-quarter revenue ($367.2M vs $243.8M, roughly 1.5× Harmony Biosciences Holdings, Inc.). Atlantic Union Bankshares Corp runs the higher net margin — 33.3% vs 9.2%, a 24.0% gap on every dollar of revenue. Over the past eight quarters, Atlantic Union Bankshares Corp's revenue compounded faster (32.7% CAGR vs 25.6%).

Atlantic Union Bankshares Corporation is a bank holding company based in Richmond, Virginia and is the parent company of Atlantic Union Bank, a regional bank. It operates 129 branches in Virginia, Maryland, and North Carolina and is the largest bank headquartered in Virginia. It is on the list of largest banks in the United States.

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

AUB vs HRMY — Head-to-Head

Bigger by revenue
AUB
AUB
1.5× larger
AUB
$367.2M
$243.8M
HRMY
Higher net margin
AUB
AUB
24.0% more per $
AUB
33.3%
9.2%
HRMY
Faster 2-yr revenue CAGR
AUB
AUB
Annualised
AUB
32.7%
25.6%
HRMY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AUB
AUB
HRMY
HRMY
Revenue
$367.2M
$243.8M
Net Profit
$122.2M
$22.5M
Gross Margin
71.9%
Operating Margin
15.8%
Net Margin
33.3%
9.2%
Revenue YoY
21.1%
Net Profit YoY
145.2%
-54.6%
EPS (diluted)
$0.84
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AUB
AUB
HRMY
HRMY
Q1 26
$367.2M
Q4 25
$387.2M
$243.8M
Q3 25
$371.0M
$239.5M
Q2 25
$402.9M
$200.5M
Q1 25
$213.3M
$184.7M
Q4 24
$218.5M
$201.3M
Q3 24
$217.2M
$186.0M
Q2 24
$208.3M
$172.8M
Net Profit
AUB
AUB
HRMY
HRMY
Q1 26
$122.2M
Q4 25
$112.0M
$22.5M
Q3 25
$92.1M
$50.9M
Q2 25
$19.8M
$39.8M
Q1 25
$49.8M
$45.6M
Q4 24
$57.8M
$49.5M
Q3 24
$76.4M
$46.1M
Q2 24
$25.2M
$11.6M
Gross Margin
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
71.9%
Q3 25
75.1%
Q2 25
81.0%
Q1 25
82.7%
Q4 24
73.0%
Q3 24
77.0%
Q2 24
81.4%
Operating Margin
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
36.6%
15.8%
Q3 25
31.3%
27.3%
Q2 25
4.3%
24.0%
Q1 25
28.8%
30.4%
Q4 24
32.6%
27.7%
Q3 24
42.4%
33.2%
Q2 24
17.6%
12.4%
Net Margin
AUB
AUB
HRMY
HRMY
Q1 26
33.3%
Q4 25
28.9%
9.2%
Q3 25
24.8%
21.2%
Q2 25
4.9%
19.8%
Q1 25
23.4%
24.7%
Q4 24
26.4%
24.6%
Q3 24
35.2%
24.8%
Q2 24
12.1%
6.7%
EPS (diluted)
AUB
AUB
HRMY
HRMY
Q1 26
$0.84
Q4 25
$0.76
$0.38
Q3 25
$0.63
$0.87
Q2 25
$0.12
$0.68
Q1 25
$0.52
$0.78
Q4 24
$0.55
$0.85
Q3 24
$0.82
$0.79
Q2 24
$0.25
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AUB
AUB
HRMY
HRMY
Cash + ST InvestmentsLiquidity on hand
$775.3M
Total DebtLower is stronger
$775.0M
$163.7M
Stockholders' EquityBook value
$5.1B
$870.2M
Total Assets
$37.3B
$1.3B
Debt / EquityLower = less leverage
0.15×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
$966.5M
$775.3M
Q3 25
$794.7M
$672.6M
Q2 25
$1.6B
$565.3M
Q1 25
$434.1M
$507.0M
Q4 24
$354.1M
$467.2M
Q3 24
$528.1M
$410.5M
Q2 24
$446.0M
$346.9M
Total Debt
AUB
AUB
HRMY
HRMY
Q1 26
$775.0M
Q4 25
$771.9M
$163.7M
Q3 25
$768.7M
$168.5M
Q2 25
$765.4M
$172.1M
Q1 25
$418.7M
$175.7M
Q4 24
$418.3M
$179.3M
Q3 24
$417.9M
$182.8M
Q2 24
$416.6M
$186.4M
Stockholders' Equity
AUB
AUB
HRMY
HRMY
Q1 26
$5.1B
Q4 25
$5.0B
$870.2M
Q3 25
$4.9B
$835.1M
Q2 25
$4.8B
$773.1M
Q1 25
$3.2B
$720.5M
Q4 24
$3.1B
$659.2M
Q3 24
$3.2B
$596.8M
Q2 24
$3.0B
$538.6M
Total Assets
AUB
AUB
HRMY
HRMY
Q1 26
$37.3B
Q4 25
$37.6B
$1.3B
Q3 25
$37.1B
$1.2B
Q2 25
$37.3B
$1.1B
Q1 25
$24.6B
$1.1B
Q4 24
$24.6B
$999.2M
Q3 24
$24.8B
$928.1M
Q2 24
$24.8B
$858.4M
Debt / Equity
AUB
AUB
HRMY
HRMY
Q1 26
0.15×
Q4 25
0.15×
0.19×
Q3 25
0.16×
0.20×
Q2 25
0.16×
0.22×
Q1 25
0.13×
0.24×
Q4 24
0.13×
0.27×
Q3 24
0.13×
0.31×
Q2 24
0.14×
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AUB
AUB
HRMY
HRMY
Operating Cash FlowLast quarter
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
$2.2B
$126.2M
Q3 25
$156.9M
$108.7M
Q2 25
$1.9B
$79.3M
Q1 25
$62.0M
$34.0M
Q4 24
$308.5M
$75.6M
Q3 24
$67.5M
$70.5M
Q2 24
$85.6M
$42.6M
Free Cash Flow
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
$126.0M
Q3 25
$108.7M
Q2 25
$79.3M
Q1 25
$33.9M
Q4 24
$75.0M
Q3 24
$70.5M
Q2 24
$42.0M
FCF Margin
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
51.7%
Q3 25
45.4%
Q2 25
39.6%
Q1 25
18.3%
Q4 24
37.3%
Q3 24
37.9%
Q2 24
24.3%
Capex Intensity
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
0.4%
Cash Conversion
AUB
AUB
HRMY
HRMY
Q1 26
Q4 25
19.98×
5.61×
Q3 25
1.70×
2.14×
Q2 25
96.20×
1.99×
Q1 25
1.25×
0.75×
Q4 24
5.34×
1.53×
Q3 24
0.88×
1.53×
Q2 24
3.40×
3.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AUB
AUB

Net Interest Income$312.4M85%
Noninterest Income$54.8M15%

HRMY
HRMY

Segment breakdown not available.

Related Comparisons